MEDP

SEC source: 0001668397-24-000129 · wk-form4_1719951463.xml · nonDerivative · entry 1

McCarthy Cornelius P. III · CIK 0001750355 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,163

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

SEC source: 0001668397-24-000127 · wk-form4_1719951114.xml · derivative · entry 2

Kraft Robert O. · CIK 0001558592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 142

Underlying: Common Stock · 72 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

F2 · derivative.exercise_date: On November 30, 2023, the Reporting Person was granted 286 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024.

F2 · derivative.expiration_date: On November 30, 2023, the Reporting Person was granted 286 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024.

SEC source: 0001668397-24-000127 · wk-form4_1719951114.xml · nonDerivative · entry 1

Kraft Robert O. · CIK 0001558592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 520

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

SEC source: 0001668397-24-000123 · wk-form4_1717791433.xml · nonDerivative · entry 1

BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

F1 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.98 to $402.115. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000121 · wk-form4_1717014244.xml · nonDerivative · entry 2

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 654,656

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $395.00 to $396.33. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000121 · wk-form4_1717014244.xml · nonDerivative · entry 1

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 660,351

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $395.00 to $396.13. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000119 · wk-form4_1716581437.xml · nonDerivative · entry 1

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 664,338

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a limit order placed by the Reporting Person during an open window period.

SEC source: 0001668397-24-000117 · wk-form4_1716409244.xml · nonDerivative · entry 1

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 664,393

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.00 to $400.50. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000105 · wk-form4_1716323543.xml · derivative · entry 2

DAVENPORT FRED B JR · CIK 0001181154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 953

Underlying: Common Stock · 953 shares

Expires 2031-05-17

F2 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

SEC source: 0001668397-24-000107 · wk-form4_1716323801.xml · derivative · entry 2

Carley Brian T · CIK 0001677791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 953

Underlying: Common Stock · 953 shares

Expires 2031-05-17

F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

SEC source: 0001668397-24-000115 · wk-form4_1716324582.xml · derivative · entry 2

McCarthy Cornelius P. III · CIK 0001750355 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 953

Underlying: Common Stock · 953 shares

Expires 2031-05-17

F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

SEC source: 0001668397-24-000113 · wk-form4_1716324412.xml · derivative · entry 2

Keating Ashley M. · CIK 0001777217 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 953

Underlying: Common Stock · 953 shares

Expires 2031-05-17

F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

SEC source: 0001668397-24-000111 · wk-form4_1716324225.xml · derivative · entry 1

Gwadry-Sridhar Femida H. · CIK 0001961974 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 953

Underlying: Common Stock · 953 shares

Expires 2031-05-17

F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

SEC source: 0001668397-24-000109 · wk-form4_1716324034.xml · derivative · entry 2

Kraft Robert O. · CIK 0001558592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 953

Underlying: Common Stock · 953 shares

Expires 2031-05-17

F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

SEC source: 0001668397-24-000103 · wk-form4_1715976696.xml · nonDerivative · entry 2

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 668,413

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.00 to $407.565. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000103 · wk-form4_1715976696.xml · nonDerivative · entry 1

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 675,473

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.00 to $407.70. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000101 · wk-form4_1715717497.xml · nonDerivative · entry 1

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 707,755

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.00 to $406.49. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000099 · wk-form4_1715372663.xml · nonDerivative · entry 2

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 712,711

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.00 to $400.67. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000099 · wk-form4_1715372663.xml · nonDerivative · entry 1

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 716,197

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.00 to $402.475. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000097 · wk-form4_1715198868.xml · nonDerivative · entry 2

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 720,979

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.00 to $408.62. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000097 · wk-form4_1715198868.xml · nonDerivative · entry 1

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 749,011

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.00 to $404.94. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000095 · wk-form4_1714766812.xml · nonDerivative · entry 2

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 773,383

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.00 to $401.60. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000095 · wk-form4_1714766812.xml · nonDerivative · entry 1

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 776,779

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.00 to $403.47. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000093 · wk-form4_1714594944.xml · nonDerivative · entry 2

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 789,713

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.00 to $400.92. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000093 · wk-form4_1714594944.xml · nonDerivative · entry 1

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 791,541

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.00 to $402.82. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000072 · wk-form4_1712094529.xml · derivative · entry 2

Carley Brian T · CIK 0001677791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 234

Underlying: Common Stock · 79 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

F2 · derivative.exercise_date: On November 30, 2023, the Reporting Person was granted 313 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024.

F2 · derivative.expiration_date: On November 30, 2023, the Reporting Person was granted 313 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024.

SEC source: 0001668397-24-000072 · wk-form4_1712094529.xml · nonDerivative · entry 1

Carley Brian T · CIK 0001677791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,674

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

SEC source: 0001668397-24-000076 · wk-form4_1712095319.xml · derivative · entry 2

Kraft Robert O. · CIK 0001558592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 214

Underlying: Common Stock · 72 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

F2 · derivative.exercise_date: On November 30, 2023, the Reporting Person was granted 286 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024.

F2 · derivative.expiration_date: On November 30, 2023, the Reporting Person was granted 286 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024.

SEC source: 0001668397-24-000076 · wk-form4_1712095319.xml · nonDerivative · entry 1

Kraft Robert O. · CIK 0001558592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 448

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

SEC source: 0001668397-24-000074 · wk-form4_1712094937.xml · derivative · entry 2

McCarthy Cornelius P. III · CIK 0001750355 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 186

Underlying: Common Stock · 63 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

F2 · derivative.exercise_date: On November 30, 2023, the Reporting Person was granted 249 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024.

F2 · derivative.expiration_date: On November 30, 2023, the Reporting Person was granted 249 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024.

SEC source: 0001668397-24-000074 · wk-form4_1712094937.xml · nonDerivative · entry 1

McCarthy Cornelius P. III · CIK 0001750355 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,101

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

SEC source: 0001668397-24-000061 · wk-form4_1710882695.xml · nonDerivative · entry 1

BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,181

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $403.00 to $403.14. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000059 · wk-form4_1710796219.xml · derivative · entry 3

Keating Ashley M. · CIK 0001777217 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,358

Underlying: Common Stock · 500 shares

Expires 2027-05-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option vested in full on May 13, 2021.

SEC source: 0001668397-24-000059 · wk-form4_1710796219.xml · nonDerivative · entry 2

Keating Ashley M. · CIK 0001777217 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250

SEC source: 0001668397-24-000059 · wk-form4_1710796219.xml · nonDerivative · entry 1

Keating Ashley M. · CIK 0001777217 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001668397-24-000057 · wk-form4_1709935676.xml · nonDerivative · entry 3

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 4,733,019

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.

F5 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $402.90 to $414.195. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001668397-24-000055 · wk-form4_1709935342.xml · nonDerivative · entry 3

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,733,019

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $402.90 to $414.195. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000057 · wk-form4_1709935676.xml · nonDerivative · entry 2

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 4,758,019

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.

F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $406.33 to $415.64. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001668397-24-000055 · wk-form4_1709935342.xml · nonDerivative · entry 2

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,758,019

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $406.33 to $415.64. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000053 · wk-form4_1709932351.xml · derivative · entry 3

Keating Ashley M. · CIK 0001777217 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 472 shares

Expires 2026-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested in full on May 14, 2020.

SEC source: 0001668397-24-000053 · wk-form4_1709932351.xml · nonDerivative · entry 2

Keating Ashley M. · CIK 0001777217 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

SEC source: 0001668397-24-000053 · wk-form4_1709932351.xml · nonDerivative · entry 1

Keating Ashley M. · CIK 0001777217 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 472

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

SEC source: 0001668397-24-000057 · wk-form4_1709935676.xml · nonDerivative · entry 1

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 4,833,019

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $406.36 to $419.42. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001668397-24-000055 · wk-form4_1709935342.xml · nonDerivative · entry 1

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,833,019

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $406.36 to $419.42. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000051 · wk-form4_1709761336.xml · derivative · entry 5

GEIGER JESSE J · CIK 0001677399 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,679 shares

Expires 2024-08-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested in full on August 5, 2019.

SEC source: 0001668397-24-000051 · wk-form4_1709761336.xml · nonDerivative · entry 3

GEIGER JESSE J · CIK 0001677399 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,503

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001668397-24-000049 · wk-form4_1709760994.xml · nonDerivative · entry 2

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 4,933,019

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.

F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.00 to $404.39. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001668397-24-000047 · wk-form4_1709760493.xml · nonDerivative · entry 2

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,933,019

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.00 to $404.39. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000051 · wk-form4_1709761336.xml · derivative · entry 4

GEIGER JESSE J · CIK 0001677399 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,679

Underlying: Common Stock · 22,321 shares

Expires 2024-08-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested in full on August 5, 2019.

SEC source: 0001668397-24-000051 · wk-form4_1709761336.xml · nonDerivative · entry 2

GEIGER JESSE J · CIK 0001677399 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,824

F1 · kind: The transactions reported on this line of this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $401.60 to $404.525. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.